Prognostic value of age and sex in early gastric cancer
β Scribed by E. Bando; N. Kojima; T. Kawamura; S. Takahashi; N. Fukushima; Y. Yonemura
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 117 KB
- Volume
- 91
- Category
- Article
- ISSN
- 0007-1323
- DOI
- 10.1002/bjs.4541
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background
The need for lymph node dissection in early gastric cancer (EGC) is controversial. The present study investigated the possibility of planning treatment for EGC according to age and sex rather than node status.
Methods
Overall survival rate and cause of death were analysed according to age (5-year increments) and sex in 4231 patients with EGC. Cox proportional hazard regression analyses were used to identify the most valuable predictor.
Results
In patients with EGC 5- and 10-year cancer-specific survival rates were 98Β·4 and 96Β·3 per cent respectively, whereas corresponding overall survival rates were 90Β·2 and 80Β·9 per cent. The critical age for determining prognosis was 70 years for men (Ο2 = 131Β·34, P < 0Β·001) and 75 years for women (Ο2 = 64Β·35, P < 0Β·001). For both sexes, the 10-year overall survival rate was less than 30 per cent in patients over 80 years old. Multivariate Cox stepwise regression analysis identified age as the most powerful prognostic indicator in EGC. The rate of death from causes unrelated to the tumour increased significantly with age, whereas that from recurrence was not affected by age.
Conclusion
Age is a better prognostic indicator than node status in both men and women with EGC. Age and sex should be taken into account as well as conventional clinicopathological variables related to lymph node metastases when determining appropriate therapy for EGC.
π SIMILAR VOLUMES
The prognostic value of DNA ploidy was evaluated in 25 patients with primary gastric leiomyosarcoma, using parafin-embedded archival specimens analysed by DNA $ow cytometry. Ploidy patterns were diploid in ten tumours and non-diploid in 15. They did not correlate with clinicopathological features of
The presence of the nuclear phosphoprotein p53 was investigated in a series of 120 consecutive gastric carcinomas. This immunohistochemical study on formalin-fixed, paraffin-embedded material found p53 expression in 43 per cent ( ~5 1 ) of carcinomas using a monoclonal antibody (DO-l), whereas no im